STAT3 INHIBITOR FORMULATION Read more about STAT3 INHIBITOR FORMULATION Australia2018248303Filed on 2018-04-05
RECOMBINANT GP120 PROTEIN WITH V1-LOOP DELETION Read more about RECOMBINANT GP120 PROTEIN WITH V1-LOOP DELETION Patent Cooperation TreatyPCT/US2019/057268Filed on 2019-10-21
VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS Read more about VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS US Patent 10,588,984Filed on 2018-09-26
HUMAN MONOCLONAL ANTIBODY TARGETING TNFR2 FOR CANCER IMMUNOTHERAPY Read more about HUMAN MONOCLONAL ANTIBODY TARGETING TNFR2 FOR CANCER IMMUNOTHERAPY US Patent 11,389,480Filed on 2019-11-18
HUMAN MONOCLONAL ANTIBODY TARGETING TNFR2 FOR CANCER IMMUNOTHERAPY Read more about HUMAN MONOCLONAL ANTIBODY TARGETING TNFR2 FOR CANCER IMMUNOTHERAPY European Patent18727536.7Filed on 2018-05-08
HUMAN MONOCLONAL ANTIBODY TARGETING TNFR2 FOR CANCER IMMUNOTHERAPY Read more about HUMAN MONOCLONAL ANTIBODY TARGETING TNFR2 FOR CANCER IMMUNOTHERAPY Canada3059472Filed on 2018-05-08
HUMAN MONOCLONAL ANTIBODY TARGETING TNFR2 FOR CANCER IMMUNOTHERAPY Read more about HUMAN MONOCLONAL ANTIBODY TARGETING TNFR2 FOR CANCER IMMUNOTHERAPY Australia2018268970Filed on 2018-05-08
METHODS FOR ISOLATING T CELLS HAVING ANTIGEN SPECIFICITY TO CANCER SPECIFIC MUTATIONS Read more about METHODS FOR ISOLATING T CELLS HAVING ANTIGEN SPECIFICITY TO CANCER SPECIFIC MUTATIONS Japan2019-182421Filed on 2019-10-02
ANTI-KRAS-G12D T CELL RECEPTORS Read more about ANTI-KRAS-G12D T CELL RECEPTORS Hong Kong19133082.8Filed on 2019-12-03
BRACHYURY POLYPEPTIDES AND METHODS FOR USE Read more about BRACHYURY POLYPEPTIDES AND METHODS FOR USE Denmark15162282.6Filed on 2008-02-27